Abstract
Antimicrobial peptides (AMPs) represent promising candidates for the design of novel microbicidal agents, effective both on planktonic, but especially on antibiotic resistant bacteria, biofilms, and persisters. In addition to their antimicrobial activity, AMPs also possess other biological activities, such as signalling molecules, immune modulators, drug delivery vehicles, which could act synergically during the anti-infectious therapy. However, for the clinical development of peptide-based therapeutics, several challenges including low specificity, susceptibility to proteolytic degradation and half-lives, potential toxicity to animal cells, need for appropriate carriers are still to be solved. The purpose of this review is to present synthetic data concerning the structure, mechanisms of action and resistance, as well as the contribution of nanotechnology and AMPs for the development of new and efficient antimicrobial strategies.
Keywords: Antimicrobial strategies, antimicrobial peptides, microbicidal, membrane pores, nanotechnology, resistance.
Graphical Abstract
Current Proteomics
Title:Contribution of Antimicrobial Peptides to the Development of New and Efficient Antimicrobial Strategies
Volume: 11 Issue: 2
Author(s): Mariana Carmen Chifiriuc, Alexandru Mihai Grumezescu, Veronica Lazar, Alexandra Bolocan, Stefanos Triaridis, Raluca Grigore and Serban Bertesteanu
Affiliation:
Keywords: Antimicrobial strategies, antimicrobial peptides, microbicidal, membrane pores, nanotechnology, resistance.
Abstract: Antimicrobial peptides (AMPs) represent promising candidates for the design of novel microbicidal agents, effective both on planktonic, but especially on antibiotic resistant bacteria, biofilms, and persisters. In addition to their antimicrobial activity, AMPs also possess other biological activities, such as signalling molecules, immune modulators, drug delivery vehicles, which could act synergically during the anti-infectious therapy. However, for the clinical development of peptide-based therapeutics, several challenges including low specificity, susceptibility to proteolytic degradation and half-lives, potential toxicity to animal cells, need for appropriate carriers are still to be solved. The purpose of this review is to present synthetic data concerning the structure, mechanisms of action and resistance, as well as the contribution of nanotechnology and AMPs for the development of new and efficient antimicrobial strategies.
Export Options
About this article
Cite this article as:
Chifiriuc Carmen Mariana, Grumezescu Mihai Alexandru, Lazar Veronica, Bolocan Alexandra, Triaridis Stefanos, Grigore Raluca and Bertesteanu Serban, Contribution of Antimicrobial Peptides to the Development of New and Efficient Antimicrobial Strategies, Current Proteomics 2014; 11 (2) . https://dx.doi.org/10.2174/157016461102140917121943
DOI https://dx.doi.org/10.2174/157016461102140917121943 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
QSAR Models for Proteins of Parasitic Organisms, Plants and Human Guests: Theory, Applications, Legal Protection, Taxes, and Regulatory Issues
Current Proteomics Angiotensin 1-7 Promotes Cardiac Angiogenesis Following Infarction
Current Vascular Pharmacology Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids
Mini-Reviews in Medicinal Chemistry The Pathophysiological Role of PEDF in Bone Diseases
Current Molecular Medicine Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions
Current Angiogenesis (Discontinued) Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries
Current Pharmaceutical Design REM Sleep Behavior Disorder and Narcolepsy
CNS & Neurological Disorders - Drug Targets Subject Index To Volume 8
Current Pharmaceutical Design Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Thermosensitive Pentablock Copolymers for Sustained Delivery of Proteins in the Treatment of Posterior Segment Diseases
Protein & Peptide Letters The Pharmacogenetics of Asthma Therapy
Current Drug Targets Functions of S100 Proteins
Current Molecular Medicine Targeting Tumorangiogenesis in Lung Cancer by Suppression of VEGF and its Receptor - Results from Clinical Trials and Novel Experimental Approaches
Current Medicinal Chemistry Clinical Management of Diabetes Mellitus in the Older Adult Patient
Current Diabetes Reviews Plant Glutathione Transferases: Structure, Antioxidant Catalytic Function and in planta Protective Role in Biotic and Abiotic Stress
Current Chemical Biology Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns
Mini-Reviews in Organic Chemistry Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Skin Response to UV Radiation
Current Drug Targets Vascular Arginase and Hypertension
Current Hypertension Reviews Dendrimers as Novel Systems for Delivery of Neuropharmaceuticals to the Brain
CNS & Neurological Disorders - Drug Targets